Letter: Levamisole.
D000818:Animals; D001416:Back Pain / Q000139:chemically induced; D002284:Carcinoma, Brown-Pearce / Q000188:drug therapy; D002986:Clinical Trials as Topic; D006224:Cricetinae; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007942:Leukemia, Experimental / Q000188:drug therapy; D007978:Levamisole / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D009362:Neoplasm Metastasis / Q000188:drug therapy; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000188:drug therapy*; D009374:Neoplasms, Experimental / Q000188:drug therapy; D009422:Nervous System Diseases / Q000139:chemically induced; D010919:Placebos; D051381:Rats; D012509:Sarcoma / Q000188:drug therapy; D012877:Skin Manifestations
D010919:Placebos; D007978:Levamisole